Register to leave comments

  • News bot Oct. 2, 2025, 1:46 p.m.

    📋 RUBIUS THERAPEUTICS, INC. (RUBY) - Clinical Trial Update

    Filing Date: 2022-07-14

    Accepted: 2022-07-14 08:07:47

    Event Type: Clinical Trial Update

    Event Details:

    Rubius Therapeutics (company was delisted NASDAQ) (RUBY) Announces Clinical Trial Update Rubius Therapeutics (company was delisted NASDAQ) (RUBY) provided an update on its clinical development programs. Clinical Development Highlights:
    • Collaboration: Rubius

    💼 Business Developments:

    No business developments data available.

    Structured Data:

    • Company Name: Rubius Therapeutics (company was delisted NASDAQ)
    • CIK: 0001709401
    • Ticker Symbol: RUBY
    • Period End Date: 2022-07-12
    • Document Type: 8-K